Lanqing Ying, Ph.D.
Dr. Lanqing Ying is interested in the roles of non-coding RNAs in cancer and utilizing RNAs as cancer therapeutics. She is also interested in cancer genomics and transcriptomics.
1) mRNA translation
Dr. Ying is interested in the molecular basis of microRNA in malignant mesothelioma. Her research goal in the Hoang Lab is to develop novel biomarkers and therapeutic strategies for targeting malignant pleural mesothelioma.
Epistasis analysis of 16S rRNA ram mutations helps define the conformational dynamics of the ribosome that influence decoding.RNA. 22(4): 499-505, 2016. [ Journal Article ]
Modification of targets related to the Entner-Doudoroff/pentose phosphate pathway route for methyl-D-erythritol 4-phosphate-dependent carotenoid biosynthesis in Escherichia coli.Microb Cell Fact. 14: 117, 2015. [ Journal Article ]
Dr. Ying received her undergraduate degree from the China Agriculture University in 2012. She started her graduate research at The Ohio State University in 2013 and obtained her Ph.D. in microbiology in 2018. At Ohio State, she studied the molecular mechanisms of translation elongation. In 2018 she joined Dr. Hoang’s lab as a visiting fellow in the Thoracic Surgery Branch at the NCI.